Eyeing $600M in peak sales, Scynexis preps ambitious launch for antifungal Brexafemme

Eyeing $600M in peak sales, Scynexis preps ambitious launch for antifungal Brexafemme
fkansteiner
Tue, 06/29/2021 – 19:32